During the 15th Five-Year Plan period, Guangzhou Pharmaceutical Group plans to invest about 10 billion to 15 billion yuan in research and development expenses, and arrange industrial investment and mergers and acquisitions of about 20 billion to 30 billion yuan to promote innovation and transformation. At the specific level of cooperation, Guangzhou Pharmaceutical Group and Moon Biotech reached a strategic cooperation to promote the industrialization of microbe-related technology; cooperated with Mathematical Group and Huawei Technology Co., Ltd., and completed the signing of the Guangyao Baiyunshan “Intelligent Pharmacovigilance Management System” project to improve the level of informatization of drug safety management. Guangzhou Pharmaceutical Group is also cooperating with Central South University, Kepton Company, and Baiyunshan Chen Liji with Macau University, Guangdong Pharmaceutical University, and Wang Laoji Health Company and Shandong Shunfeng Biotechnology Co., Ltd. to promote industry-university-research collaboration. In the new business direction, Guangzhou Pharmaceutical Group signed a cooperation agreement with the Guangzhou Development Zone Management Committee, Baiyunshan Nuclear Medicine Company, the First Affiliated Hospital of Sun Yat-sen University, the First Affiliated Hospital of Jinan University, GE Medical, etc. to promote the development of the entire nuclear medicine industry chain; Guangzhou Pharmaceutical Animal Insurance Technology Co., Ltd. signed a cooperation agreement with Ruipai Pet Hospital Management Company and Beijing Nuohe Animal Insurance Technology Co., Ltd. to develop animal health care business; Guoshu Research Institute and Zhanjiang Agricultural Reclamation Research Institute signed cooperation agreements to carry out cultivation tests on new varieties of facilities. In addition, in order to speed up capital operations, Guangzhou Pharmaceutical Capital has also signed cooperation agreements with a number of companies to expand its industrial footprint.

During the 15th Five-Year Plan period, Guangzhou Pharmaceutical Group plans to invest about 10 billion to 15 billion yuan in research and development expenses, and arrange industrial investment and mergers and acquisitions of about 20 billion to 30 billion yuan to promote innovation and transformation. At the specific level of cooperation, Guangzhou Pharmaceutical Group and Moon Biotech reached a strategic cooperation to promote the industrialization of microbe-related technology; cooperated with Mathematical Group and Huawei Technology Co., Ltd., and completed the signing of the Guangyao Baiyunshan “Intelligent Pharmacovigilance Management System” project to improve the level of informatization of drug safety management. Guangzhou Pharmaceutical Group is also cooperating with Central South University, Kepton Company, and Baiyunshan Chen Liji with Macau University, Guangdong Pharmaceutical University, and Wang Laoji Health Company and Shandong Shunfeng Biotechnology Co., Ltd. to promote industry-university-research collaboration. In the new business direction, Guangzhou Pharmaceutical Group signed a cooperation agreement with the Guangzhou Development Zone Management Committee, Baiyunshan Nuclear Medicine Company, the First Affiliated Hospital of Sun Yat-sen University, the First Affiliated Hospital of Jinan University, GE Medical, etc. to promote the development of the entire nuclear medicine industry chain; Guangzhou Pharmaceutical Animal Insurance Technology Co., Ltd. signed a cooperation agreement with Ruipai Pet Hospital Management Company and Beijing Nuohe Animal Insurance Technology Co., Ltd. to develop animal health care business; Guoshu Research Institute and Zhanjiang Agricultural Reclamation Research Institute signed cooperation agreements to carry out cultivation tests on new varieties of facilities. In addition, in order to speed up capital operations, Guangzhou Pharmaceutical Capital has also signed cooperation agreements with a number of companies to expand its industrial footprint.